Anti-VEGF’s in DR, AMD & RVO

Developer: Med Learning Group

Category: Medical

~50 - 100

1 ratings

~50 (installs week)

Trend Steady

ASO Keyword Dashboard

Tracking 18 keywords for Anti-VEGF’s in DR, AMD & RVO in Apple App Store

Developer: Med Learning Group Category: medical Rating: 5

Anti-VEGF’s in DR, AMD & RVO tracks 18 keywords (no keywords rank yet; 18 need traction). Key metrics: opportunity 48.6, difficulty 32.3.

Tracked keywords

0 ranked • 18 not ranking yet

Top 10 coverage

—

Best rank — • Latest leader —

Avg opportunity

48.6

Top keyword: well

Avg difficulty

32.3

Lower scores indicate easier wins

Opportunity leaders

well

Opportunity: 58.0 • Difficulty: 49.3 • Rank —

Competitors: 296
72.1
eye

Opportunity: 58.0 • Difficulty: 42.6 • Rank —

Competitors: 97
60.9
augmented reality

Opportunity: 57.0 • Difficulty: 31.2 • Rank —

Competitors: 20
45.5
affecting

Opportunity: 57.0 • Difficulty: 23.8 • Rank —

Competitors: 4
36.5
animation

Opportunity: 57.0 • Difficulty: 35.9 • Rank —

Competitors: 37
54.1

Unranked opportunities

well

Opportunity: 58.0 • Difficulty: 49.3 • Competitors: 296
eye

Opportunity: 58.0 • Difficulty: 42.6 • Competitors: 97
augmented reality

Opportunity: 57.0 • Difficulty: 31.2 • Competitors: 20
affecting

Opportunity: 57.0 • Difficulty: 23.8 • Competitors: 4
animation

Opportunity: 57.0 • Difficulty: 35.9 • Competitors: 37

High competition keywords

well

Total apps: 1,543 • Major competitors: 296

Latest rank: — • Difficulty: 49.3
eye

Total apps: 494 • Major competitors: 97

Latest rank: — • Difficulty: 42.6
target

Total apps: 327 • Major competitors: 63

Latest rank: — • Difficulty: 41.5
growth

Total apps: 251 • Major competitors: 52

Latest rank: — • Difficulty: 36.5
animation

Total apps: 246 • Major competitors: 37

Latest rank: — • Difficulty: 35.9

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
augmented reality	57	100	31	46 102 competing apps Median installs: 235,912 Avg rating: 4.6	—	—	20 major competitor apps
well	58	100	49	72 1,543 competing apps Median installs: 241,700 Avg rating: 4.6	—	—	296 major competitor apps
affecting	57	100	24	36 40 competing apps Median installs: 233,512 Avg rating: 4.6	—	—	4 major competitor apps
animation	57	100	36	54 246 competing apps Median installs: 236,112 Avg rating: 4.6	—	—	37 major competitor apps
growth	57	100	36	54 251 competing apps Median installs: 213,975 Avg rating: 4.7	—	—	52 major competitor apps
target	57	100	42	57 327 competing apps Median installs: 243,000 Avg rating: 4.7	—	—	63 major competitor apps
reality	57	100	38	53 231 competing apps Median installs: 285,900 Avg rating: 4.6	—	—	53 major competitor apps
eye	58	100	43	61 494 competing apps Median installs: 253,488 Avg rating: 4.6	—	—	97 major competitor apps
retina	57	100	32	45 94 competing apps Median installs: 190,525 Avg rating: 4.6	—	—	12 major competitor apps
augmented	57	100	35	48 138 competing apps Median installs: 224,188 Avg rating: 4.6	—	—	28 major competitor apps
factor	57	100	41	48 131 competing apps Median installs: 328,600 Avg rating: 4.7	—	—	31 major competitor apps
production	57	100	32	47 123 competing apps Median installs: 198,400 Avg rating: 4.7	—	—	20 major competitor apps
vascular	0	18	7	11 2 competing apps Median installs: 98,850 Avg rating: 4.8	—	—	0 major competitor apps
medications	20	100	37	41 67 competing apps Median installs: 257,000 Avg rating: 4.7	—	—	17 major competitor apps
briefly	0	26	12	14 3 competing apps Median installs: 116,025 Avg rating: 4.5	—	—	1 major competitor apps
describing	56	100	20	27 14 competing apps Median installs: 151,638 Avg rating: 4.7	—	—	2 major competitor apps
positively	56	100	25	29 19 competing apps Median installs: 330,900 Avg rating: 4.6	—	—	2 major competitor apps
affects	57	100	41	37 44 competing apps Median installs: 208,275 Avg rating: 4.7	—	—	5 major competitor apps

App Description

Augmented reality animation briefly describing how vascular endothelial growth factor (VEGF) negatively affects the retina in DR, AMD and RVO, as well as how medications injected into the eye can target VEGF production and activity, positively affecting vision.